TY - JOUR
T1 - Stillbirths
T2 - Recall to action in high-income countries
AU - For The Lancet Ending Preventable Stillbirths study group and The Lancet Stillbirths In High-Income Countries Investigator Group
AU - Flenady, Vicki
AU - Wojcieszek, Aleena M.
AU - Middleton, Philippa
AU - Ellwood, David
AU - Erwich, Jan Jaap
AU - Coory, Michael
AU - Khong, T. Yee
AU - Silver, Robert M.
AU - Smith, Gordon C.S.
AU - Boyle, Frances M.
AU - Lawn, Joy E.
AU - Blencowe, Hannah
AU - Hopkins Leisher, Susannah
AU - Gross, Mechthild M.
AU - Horey, Dell
AU - Farrales, Lynn
AU - Bloomfield, Frank
AU - McCowan, Lesley
AU - Brown, Stephanie J.
AU - Joseph, K. S.
AU - Zeitlin, Jennifer
AU - Reinebrant, Hanna E.
AU - Ravaldi, Claudia
AU - Vannacci, Alfredo
AU - Cassidy, Jillian
AU - Cassidy, Paul
AU - Farquhar, Cindy
AU - Wallace, Euan
AU - Siassakos, Dimitrios
AU - Heazell, Alexander E.P.
AU - Storey, Claire
AU - Sadler, Lynn
AU - Petersen, Scott
AU - Frøen, J. Frederik
AU - Goldenberg, Robert L.
AU - Sisassakos, D.
AU - Kinney, Mary V.
AU - de Bernis, Luc
AU - Heazell, Alexander
AU - Ruidiaz, Jessica
AU - Carvalho, Andre
AU - Dahlstrom, Jane
AU - East, Christine
AU - Fox, Jane P.
AU - Gibbons, Kristen
AU - Ibiebele, Ibinabo
AU - Kildea, Sue
AU - Gardener, Glenn
AU - Lourie, Rohan
AU - Cacciatore, Joanne
N1 - Publisher Copyright: © 2016 Elsevier Ltd.
PY - 2016/2/13
Y1 - 2016/2/13
N2 - Summary Variation in stillbirth rates across high-income countries and large equity gaps within high-income countries persist. If all high-income countries achieved stillbirth rates equal to the best performing countries, 19 439 late gestation (28 weeks or more) stillbirths could have been avoided in 2015. The proportion of unexplained stillbirths is high and can be addressed through improvements in data collection, investigation, and classification, and with a better understanding of causal pathways. Substandard care contributes to 20-30% of all stillbirths and the contribution is even higher for late gestation intrapartum stillbirths. National perinatal mortality audit programmes need to be implemented in all high-income countries. The need to reduce stigma and fatalism related to stillbirth and to improve bereavement care are also clear, persisting priorities for action. In high-income countries, a woman living under adverse socioeconomic circumstances has twice the risk of having a stillborn child when compared to her more advantaged counterparts. Programmes at community and country level need to improve health in disadvantaged families to address these inequities.
AB - Summary Variation in stillbirth rates across high-income countries and large equity gaps within high-income countries persist. If all high-income countries achieved stillbirth rates equal to the best performing countries, 19 439 late gestation (28 weeks or more) stillbirths could have been avoided in 2015. The proportion of unexplained stillbirths is high and can be addressed through improvements in data collection, investigation, and classification, and with a better understanding of causal pathways. Substandard care contributes to 20-30% of all stillbirths and the contribution is even higher for late gestation intrapartum stillbirths. National perinatal mortality audit programmes need to be implemented in all high-income countries. The need to reduce stigma and fatalism related to stillbirth and to improve bereavement care are also clear, persisting priorities for action. In high-income countries, a woman living under adverse socioeconomic circumstances has twice the risk of having a stillborn child when compared to her more advantaged counterparts. Programmes at community and country level need to improve health in disadvantaged families to address these inequities.
UR - http://www.scopus.com/inward/record.url?scp=84957846843&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84957846843&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(15)01020-X
DO - 10.1016/S0140-6736(15)01020-X
M3 - Review article
C2 - 26794070
SN - 0140-6736
VL - 387
SP - 691
EP - 702
JO - The Lancet
JF - The Lancet
IS - 10019
ER -